​

Akero Therapeutics Ownership | Who Owns Akero Therapeutics?

OverviewForecastFinancialsChart

Akero Therapeutics Ownership Summary

Akero Therapeutics is owned by 112.70% institutional investors, 1.14% insiders. Wellington management group llp is the largest institutional shareholder, holding 10.62% of AKRO shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.01% of its assets in Akero Therapeutics shares.

AKRO Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockAkero Therapeutics112.70%1.14%-13.84%
SectorHealthcare Stocks 486.50%11.08%-397.59%
IndustryBiotech Stocks 304.14%11.08%-215.23%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Wellington management group llp7.38M10.62%$205.23M
Blackrock5.59M9.42%$131.06M
Janus henderson group6.03M8.69%$167.77M
Blackrock funding, inc. /de5.78M7.07%$308.39M
General atlantic5.73M7.02%$305.97M
Rtw investments, lp5.48M6.70%$292.28M
Price t rowe associates inc /md/4.32M6.22%$120.24M
Vanguard group3.70M5.33%$103.06M
Avoro capital advisors3.50M4.28%$186.76M
Deep track capital, lp3.04M3.72%$162.35M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
University of wisconsin foundation328.50K19.61%$17.53M
Allostery investments lp22.50K15.29%$1.20M
Propel bio management228.88K14.82%$12.21M
General atlantic5.73M8.43%$305.97M
Foresite capital management vi244.90K7.35%$13.07M
Logos global management lp1.20M7.08%$64.03M
Silverarc capital management713.81K7.02%$38.09M
Deep track capital, lp3.04M5.21%$162.35M
Redmile group774.31K4.40%$41.32M
Rtw investments, lp5.48M4.16%$292.28M

Top Buyers

HolderShares% AssetsChange
Avoro capital advisors3.50M3.27%3.50M
Point72 asset management2.71M0.28%2.20M
Holocene advisors, lp1.08M0.14%1.08M
Bellevue group1.99M2.33%734.61K
Blackrock5.59M0.00%694.02K

Top Sellers

HolderShares% AssetsChange
Rtw investments, lp5.48M4.16%-1.94M
Braidwell lp---1.08M
Janus henderson group6.03M0.09%-1.04M
T. rowe price investment management---670.05K
Pfizer---562.63K

New Positions

HolderShares% AssetsChangeValue
Avoro capital advisors3.50M3.27%3.50M$186.76M
Holocene advisors, lp1.08M0.14%1.08M$57.40M
Frazier life sciences management366.78K0.78%366.78K$19.57M
Siren318.65K0.88%318.65K$17.00M
Pfm health sciences, lp266.17K1.22%266.17K$14.20M

Sold Out

HolderChange
Newedge advisors-7.00
Svb wealth-8.00
Nelson, van denburg & campbell wealth management group-12.00
Riggs asset managment-14.00
Continuum advisory-18.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20252798.98%92,103,2386.56%1120.93%144-14.29%8978.00%
Mar 31, 202528-86.07%15,857,543-78.62%200.18%14-87.16%7-86.00%
Dec 31, 202419810.00%74,179,4721.61%1060.97%10727.38%50-12.28%
Sep 30, 202418014.65%72,997,3861.71%1050.72%858.97%577.55%
Jun 30, 2024157-15.14%71,768,872-1.77%1210.80%78-29.09%5312.77%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv2.41M3.01%-50.45K
Vanguard US Total Market Shares ETF1.94M2.55%2.50K
iShares Russell 2000 ETF1.65M2.06%-31.29K
T. Rowe Price New Horizons1.63M2.04%21.82K
US Small-Cap Growth II Equity Comp1.63M2.04%-184.44K
Janus Henderson Global Life Sciences1.44M1.80%-117.23K
Janus Henderson Global Life Sciences D1.44M1.80%-59.07K
Vanguard Health Care Inv1.26M1.58%-2.40M
Janus Henderson Glb Life Scn I2 USD1.18M1.49%-29.71K
Janus Global Life Science AUSD1.18M1.48%-75.10K

Recent Insider Transactions

DateNameRoleActivityValue
Aug 12, 2025Young Jonathan Chief Operating OfficerSell$532.14K
Aug 12, 2025Young Jonathan Chief Operating OfficerSell$65.19K
Aug 11, 2025Cheng Andrew President and CEOSell$918.91K
Aug 11, 2025Cheng Andrew President and CEOSell$518.92K
Aug 11, 2025Cheng Andrew President and CEOSell$19.77K

Insider Transactions Trends

DateBuySell
2025 Q3-16
2025 Q2-45
2025 Q1439
2024 Q4-31
2024 Q3-26

AKRO Ownership FAQ

Who Owns Akero Therapeutics?

Akero Therapeutics shareholders are primarily institutional investors at 112.70%, followed by 1.14% insiders and -13.84% retail investors. The average institutional ownership in Akero Therapeutics's industry, Biotech Stocks , is 304.14%, which Akero Therapeutics falls below.

Who owns the most shares of Akero Therapeutics?

Akero Therapeutics’s largest shareholders are Wellington management group llp (7.38M shares, 10.62%), Blackrock (5.59M shares, 9.42%), and Janus henderson group (6.03M shares, 8.69%). Together, they hold 28.73% of Akero Therapeutics’s total shares outstanding.

Does Blackrock own Akero Therapeutics?

Yes, BlackRock owns 9.42% of Akero Therapeutics, totaling 5.59M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 131.06M$. In the last quarter, BlackRock increased its holdings by 694.02K shares, a 14.19% change.

Who is Akero Therapeutics’s biggest shareholder by percentage of total assets invested?

University of wisconsin foundation is Akero Therapeutics’s biggest shareholder by percentage of total assets invested, with 19.61% of its assets in 328.5K Akero Therapeutics shares, valued at 17.53M$.

Who is the top mutual fund holder of Akero Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Akero Therapeutics shares, with 3.01% of its total shares outstanding invested in 2.41M Akero Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools